Event Group

Event Group

Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.

Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.

Event Group path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Group

Event Group


Ignite Creation Date: 2025-12-25 @ 12:46 AM
Ignite Modification Date: 2025-12-25 @ 10:59 PM
NCT ID: NCT04080167
Group ID: EG000
Title: Arm 1 (InCharge Health App) - Sickle Cell Disease (SCD) Patients
Description: Sickle cell patients meeting the eligibility requirements for the study. Patient receives the InCharge Health app for 6 months InCharge Health mobile application: The InCharge Health app features include: Daily reminders; Ability to customize content of message and time of day when the message comes; Symptom tracker to monitor daily pain and mood; 7-day streak that tracks daily adherence; Graphing adherence against pain symptoms; Communication feature allowing the patient to connect to the clinic and a "health partner"; Link to discussion forum where communication to other patients can occur; Education bank that provides information about SCD and hydroxyurea. Participants can delay daily push notifications. If hospitalized, participants may stop notifications. A special feature of the app is to set up a "health partner", who may be a person the participant may choose from his/her contact list and who will receive notifications if it had been \<4 hours since not documenting the use of hydroxyurea. The "app healthy partner" will be encouraged to message the participant to remind him/her to take the medication.
Deaths Number Affected: 3
Deaths Number At Risk: None
Serious Number Affected: 0
Serious Number At Risk: 293
Other Number Affected: 0
Other Number At Risk: 293
Study: NCT04080167
Results Section: NCT04080167
Adverse Events Module: NCT04080167